This discovery gives hope for a more effective and cheaper treatment strategy to millions worldwide suffering from chronic infections
1. A recent discovery by scientists at A*A*STAR’s Singapore Institute for Clinical Sciences (SICS), in close collaboration with researchers at the Singapore Immunology Network (SIgN), provides hope for a new personalised treatment strategy that could use a patient’s own blood to treat the infection. This could help treat millions of people living with chronic infections such as HIV, Hepatitis B or Hepatitis C. These findings were published in the August 2013 issue of The Journal of Clinical Investigation.
2. Patients suffering from chronic infections often have to undergo long periods of anti-viral drug therapy to control the virus. Anti-viral drugs are not fully effective against viruses such as Hepatitis B and Hepatitis C, which have chronically-infected about 400 million worldwide with more than 1,000,000 people dying from Hepatitis-related diseases every year.
3. Vaccines are a potentially effective means to treat chronic viral infections such as this because they can eliminate the virus naturally. However, vaccines for patients with chronic infections are often difficult to produce since these patients already have weak immune responses or the vaccine is not effective due to genetic diversity amongst viruses.
4. The team at SICS led by Prof Antonio Bertoletti has discovered that monocytes, a type of white blood cell that can activate an immune response, are able to capture the virus in chronically-infected patients and use the captured virus to boost the patient’s own immune response.
5. By using the viral antigen already present in the blood of the patient suffering from a chronic illness, this strategy redefines therapeutic vaccines by cutting down on time and resources as there is no need to specially isolate the viral proteins from patients, purify it, and then inactivate it to create a vaccine.
6. All the proteins present within the virus can be used to create a personalised vaccine for each individual. This also means that many of the complex issues associated with current vaccine therapy against chronic infections can be overcome, such as that of genetic diversity of viruses.
7. One of the greatest beneficiaries of this discovery would be chronically-infected patient populations in lower socio-economic strata. By tailoring vaccines to be more specific to each virus and each patient, vaccine production can be simplified and thus less costly. Vaccines produced via this discovery could improve the accessibility of such treatments.
The Latest on: Chronic Infections
- Cancer Immunotherapy Likely Safe, Effective for Those With HIV, Other Infections, Study Suggestson January 12, 2020 at 8:46 am
Although the researchers state that more studies are needed to validate their findings, they found that patients who also had HIV, HBV, or HCV who were being treated with ICI therapy had similar rates ...
- A ‘shocking’ new way to treat infectionson January 12, 2020 at 3:24 am
However, a persistent problem plagues metal-based implants: the surface is also a perfect home for microbes to accumulate, causing chronic infections and inflammation in the surrounding tissue.
- Scientists examine how a gut infection may produce chronic symptomson January 10, 2020 at 2:00 pm
Sometimes the end of an intestinal infection is just the beginning of more misery. Of those who contract traveler's diarrhea, for example, an unlucky few go on to develop irritable bowel syndrome (IBS ...
- Varicella Zoster Infection Treatment Market to Raise at a CAGR of 4.2% over the Forecast Period 2017 – 2027on January 10, 2020 at 2:30 am
VALLEY COTTAGE, N.Y. - Future Market Insights (FMI) has published a new report on the varicella zoster infection treatment market titled "Varicella Zoster Infection Treatment Market: Global Industry ...
- Infection rewires liver metabolismon January 9, 2020 at 2:49 pm
However, the link between these two functions is poorly understood. To study this link, Lercher et al. infected mice with chronic lymphocytic choriomeningitis virus (LCMV). Infection caused pronounced ...
- Justin Bieber says he has Lyme disease and chronic mono affecting his 'skin, brain function, energy, and overall health'on January 9, 2020 at 11:53 am
Bieber joins the ranks of the many celebrities with the controversial disease. Antibiotics are the only treatment, and don't always work.
- The Assistance Fund Opens New Program for Chronic Granulomatous Diseaseon January 9, 2020 at 9:00 am
/PRNewswire/ -- The Assistance Fund (TAF), an independent charitable patient assistance foundation that helps patients and families facing high ...
- Patients push limits for clues to chronic fatigue syndromeon January 9, 2020 at 4:43 am
Chronic fatigue syndrome is one of medicine's most vexing ... Like many such patients, Ault's disease struck following a run-of-the-mill infection in 2017. He'd been training for a half-marathon but ...
- Healthcare Acquired Infection Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2025 – Market Research Engineon January 9, 2020 at 4:11 am
New York, January 09, 2020: The report scope includes detailed competitive outlook covering Market shares and profiles key participants in the global Healthcare Acquired Infection Market share. Major ...
- Justin Bieber reveals he has Lyme disease - what is the infection?on January 9, 2020 at 2:05 am
The Canadian pop sensation told his 124m Instagram followers he “recently” discovered he had the bacterial infection after a “rough couple years”.
via Google News and Bing News